Kentucky Governor Signs Bill Legalizing Medical Marijuana

A day after it was approved by the state’s legislature, Kentucky Governor Andy Beshea signed into law legislation that legalizes medical marijuana.

Governor Beshea wasted no time in making his state the latest to legalize the medical use of marijuana. The bill’s signing came a day after the House of Representatives voted 66 to 33 to pass Senate Bill 47, which had already passed the Senate 26 to 11.

Senate Bill 47 legalizes the possession and use of medical marijuana for those with a qualifying medical condition who receive a recommendation from a physician or advanced practice registered nurse. Licensed dispensaries will be allowed to distribute marijuana and marijuana products. Although smoking marijuana isn’t allowed, dried flower is still permitted for vaping, and patients will be able to obtain marijuana through a variety of other products.

Senate Bill 47 also explicitly recognizes “valid out-of-state registry identification cards”.

The bill states that the “acquisition, blending, cultivation, delivery, distribution, manufacturing,  manipulation, packaging for sale, preparation, possession, sale, testing, transportation, or transfer of medicinal cannabis or medicinal cannabis accessories by a cannabis business or cannabis business agent shall be considered lawful”. Under the law the state is required to license at least 25 medical marijuana dispensaries throughout the state. They would also be required to license at least 15 cultivators, five processors and three producers.

Qualifying medical marijuana conditions include:

  • Any type or form of cancer regardless of stage;
  • Chronic, severe, intractable, or debilitating pain;
  • Epilepsy or any other intractable seizure disorder;
  • Multiple sclerosis, muscle spasms, or spasticity;
  • Chronic nausea or cyclical vomiting syndrome that has proven resistant to other conventional medical treatments;
  • Post-traumatic stress disorder
  • Any other medical condition or disease for which the Kentucky Center for Cannabis established in KRS 164.983, or its successor, determines that sufficient scientific data and evidence exists to demonstrate that an individual diagnosed with that condition or disease is likely to receive medical, therapeutic, or palliative benefits from the use of medicinal cannabis.

Another provision of the bill states that a medical marijuana patient “otherwise entitled to custody of, or visitation time or parenting time with, a minor child shall not be denied that right, and there shall be no presumption of abuse, neglect, or dependency for conduct permitted under Sections 1 to 30 of this Act unless the person’s actions in relation to medicinal cannabis created an unreasonable danger to the safety of the minor child as established by clear and convincing evidence.”

In regards to out-of-state patients, the bill says:

A visiting qualified patient shall not be subject, under the laws of the Commonwealth, to arrest, prosecution, or denial of any right or privilege, including but not limited to civil penalty or disciplinary action by a court or occupational or professional licensing board, for the use of medicinal cannabis, if the visiting qualified patient does not possess more than an amount of medicinal cannabis determined by the cabinet to constitute an uninterrupted ten (10) day supply on his or her person.

For the full text of Kentucky’s Senate Bill 47, click here.

Senate Bill 47 will take effect on January 1, 2025.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can signup for our newsletter by clicking here

 

 

More articles from The Marijuana Herald.

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells